Deal Team

Corporate

Elanco Animal Health Incorporated in its Cooperation Agreement with Ancora Holdings Group LLC

On April 1, 2024, Elanco Animal Health Incorporated (NYSE: ELAN) announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors.  In connection with the announcement, Elanco has entered into a Cooperation Agreement with Ancora Holdings Group LLC and its affiliates.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Elanco.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.